Reuters logo
BRIEF-PolarityTE ‍multiple value analysis committees have approved Skinte for use at their respective medical institutions​
October 19, 2017 / 12:07 PM / a month ago

BRIEF-PolarityTE ‍multiple value analysis committees have approved Skinte for use at their respective medical institutions​

Oct 19 (Reuters) - PolarityTE Inc

* PolarityTE Inc - ‍Multiple value analysis committees have approved Skinte for use at their respective medical institutions​

* PolarityTE Inc - ‍Clinical application for skinte is expected in Q4 of 2017, and data is planned to be released through multiple channels in H1 2018​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below